NL
IONS icon

NWAM LLC’s Ionis Pharmaceuticals IONS Stock Holding History

NWAM LLC’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Hold
3,238
– – 0.01% 602
2026
Q1 		$243K Hold
3,238
– – 0.01% 554
2025
Q4 		$262K Hold
3,238
– – 0.01% 537
2025
Q3 		$238K Buy
+3,238
New +$158K 0.01% 570

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

NWAM LLC's IONS Position: Q2 2026 in Review

NWAM LLC held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 3,238 shares worth $257K. The position accounts for 0.01% of the portfolio, ranked #602.

NWAM LLC first reported a position in IONS in Q3 2025 and has held it in 4 quarters since. The position peaked at $262K in Q4 2025. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • NWAM LLC held 3,238 shares of Ionis Pharmaceuticals worth $257K as of Q2 2026.
  • NWAM LLC left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up 0.01% of NWAM LLC's portfolio in Q2 2026, its #602 holding.
  • NWAM LLC first reported a position in Ionis Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • NWAM LLC's Ionis Pharmaceuticals position peaked at $262K in Q4 2025.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on NWAM LLC's 13F filing for Q2 2026, filed 23 Jul 2026.